Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study

William J. Irvin, Christine M. Walko, Karen E. Weck, Joseph G. Ibrahim, Wing K. Chiu, E. Claire Dees, Susan G. Moore, Oludamilola A. Olajide, Mark L. Graham, Sean T. Canale, Rachel E. Raab, Steven W. Corso, Jeffrey M. Peppercorn, Steven M. Anderson, Kenneth J. Friedman, Evan T. Ogburn, Zeruesenay Desta, David A. Flockhart, Howard L. McLeod, James P. Evans, Lisa A. Carey

Open source

DOI: 10.1200/jco.2010.31.4427
Published: 2011-08-20
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco.2010.31.4427,
  title = {Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study},
  author = {William J. Irvin and Christine M. Walko and Karen E. Weck and Joseph G. Ibrahim and Wing K. Chiu and E. Claire Dees and Susan G. Moore and Oludamilola A. Olajide and Mark L. Graham and Sean T. Canale and Rachel E. Raab and Steven W. Corso and Jeffrey M. Peppercorn and Steven M. Anderson and Kenneth J. Friedman and Evan T. Ogburn and Zeruesenay Desta and David A. Flockhart and Howard L. McLeod and James P. Evans and Lisa A. Carey},
  year = {2011},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco.2010.31.4427},
  url = {https://doi.org/10.1200/jco.2010.31.4427}
}

RIS

TY  - JOUR
TI  - Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study
AU  - William J. Irvin
AU  - Christine M. Walko
AU  - Karen E. Weck
AU  - Joseph G. Ibrahim
AU  - Wing K. Chiu
AU  - E. Claire Dees
AU  - Susan G. Moore
AU  - Oludamilola A. Olajide
AU  - Mark L. Graham
AU  - Sean T. Canale
AU  - Rachel E. Raab
AU  - Steven W. Corso
AU  - Jeffrey M. Peppercorn
AU  - Steven M. Anderson
AU  - Kenneth J. Friedman
AU  - Evan T. Ogburn
AU  - Zeruesenay Desta
AU  - David A. Flockhart
AU  - Howard L. McLeod
AU  - James P. Evans
AU  - Lisa A. Carey
PY  - 2011
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco.2010.31.4427
UR  - https://doi.org/10.1200/jco.2010.31.4427
ER  -

APA

Irvin, W. J., Walko, C. M., Weck, K. E., Ibrahim, J. G., Chiu, W. K., Dees, E. C., Moore, S. G., Olajide, O. A., Graham, M. L., Canale, S. T., Raab, R. E., Corso, S. W., Peppercorn, J. M., Anderson, S. M., Friedman, K. J., Ogburn, E. T., Desta, Z., Flockhart, D. A., McLeod, H. L., Evans, J. P., & Carey, L. A. (2011). Genotype-Guided Tamoxifen Dosing Increases Active Metabolite Exposure in Women With Reduced CYP2D6 Metabolism: A Multicenter Study. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2010.31.4427

Source records

crossref · retrieved 2026-09-25T05:46:06.009Z